About MEDarchon
MEDarchon is a company based in Nashville (United States) founded in 2012 was acquired by XSOLIS in November 2019. MEDarchon has raised $1.83 million across 2 funding rounds from investors including XSOLIS, West End Holdings and Nuecura Partners. MEDarchon offers products and services including Slotfb Platform. MEDarchon operates in a competitive market with competitors including Vocera, Spok, OptimizeRx, HealthCrowd and TelMedIQ, among others.
- Headquarter Nashville, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MEDarchon
MEDarchon offers a comprehensive portfolio of products and services, including Slotfb Platform.
Platform for playing and registering slot games securely.
Funding Insights of MEDarchon
MEDarchon has successfully raised a total of $1.83M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.6 million completed in August 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MEDarchon
MEDarchon has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include XSOLIS, West End Holdings and Nuecura Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
West End Holdings is engaged in private equity investments.
|
Locked | Locked | Locked | |
|
Healthcare investments are managed by Nuecura Partners.
|
Locked | Locked | Locked | |
|
AI-based platform for physicians and payers to analyze denial management
|
Locked | Locked | Locked |
Investor details for MEDarchon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MEDarchon
Investment portfolio details for MEDarchon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MEDarchon
Detailed financials for MEDarchon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medarchon Comparisons
Peer comparison for MEDarchon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MEDarchon
MEDarchon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vocera, Spok, OptimizeRx, HealthCrowd and TelMedIQ, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based messaging and workflow solutions are delivered for healthcare providers.
|
|
| Locked | Locked | Locked |
Secure messaging and clinical alerting solutions are provided for healthcare.
|
|
| Locked | Locked | Locked |
Cloud-based platform enables hospital point-of-care communication management.
|
|
| Locked | Locked | Locked |
AI and cloud-based platform is provided for healthcare provider communications.
|
|
| Locked | Locked | Locked |
HIPAA-compliant secure messaging is delivered for healthcare communications.
|
|
| Locked | Locked | Locked |
Healthcare professionals are connected via an AI-based digital platform.
|
Detailed competitors of MEDarchon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medarchon
Complete news archive for MEDarchon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MEDarchon
MEDarchon was founded in 2012 and raised its 1st funding round 1 year after it was founded.
MEDarchon is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
MEDarchon is a funded company, having raised a total of $1.83M across 2 funding rounds to date.
MEDarchon provides medical professionals a system to text through a secure smartphone application.The app determines whom to the message should go and with what urgency based on the issue and time of day. The requests get assigned to some other staff member if the message is not viewed in a certain amount. Also, they have a patented analytics system that helps identify when patients are at risk based on communication problems.
MEDarchon's top competitors include Vocera, OptimizeRx and MediShout.
MEDarchon offers Slotfb Platform.
MEDarchon has 3 investors. Key investors include XSOLIS, West End Holdings, and Nuecura Partners.